BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22938817)

  • 1. 17β-Oestradiol activates proteolysis and increases invasion through phosphatidylinositol 3-kinase pathway in human cervical cancer cells.
    Huang Y; Li J; Xiang L; Han D; Shen X; Wu X
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):307-12. PubMed ID: 22938817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells.
    Zhu H; Zheng J; Xiao X; Zheng S; Dong K; Liu J; Wang Y
    Oncol Rep; 2010 Jan; 23(1):129-39. PubMed ID: 19956873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
    Iwasaki M; Nishikawa A; Fujimoto T; Akutagawa N; Manase K; Endo T; Yoshida K; Maekawa R; Yoshioka T; Kudo R
    Gynecol Oncol; 2002 Apr; 85(1):103-7. PubMed ID: 11925127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY; Yao JF; Chen XD
    Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells.
    Choi JH; Choi KC; Auersperg N; Leung PC
    Cancer Res; 2006 Apr; 66(7):3912-20. PubMed ID: 16585220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
    Ryzhakova OS; Solov'eva NI
    Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of alphavbeta3 integrin receptor in the invasive potential of human cervical cancer (SiHa) cells.
    Chatterjee N; Chatterjee A
    J Environ Pathol Toxicol Oncol; 2001; 20(3):211-21. PubMed ID: 11797830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.
    Kato Y; Yamashita T; Ishikawa M
    Oncol Rep; 2002; 9(3):565-9. PubMed ID: 11956628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells.
    Ramer R; Eichele K; Hinz B
    Oncogene; 2007 Aug; 26(39):5822-7. PubMed ID: 17369856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H; Lin QD; Qiao C
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
    Collins HM; Morris TM; Watson SA
    Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
    You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
    Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
    Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
    Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
    Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.